allosteric NMDA agonists (University of Nebraska Medical Center/University of Bristol)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameallosteric NMDA agonists (University of Nebraska Medical Center/University of Bristol)
Drug Alias Namenaphthalene/phenanthrene derivatives (University of Nebraska Medical Center/University of Bristol)UBP-551
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsGlutamate [NMDA] receptor agonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsMental DisordersNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMental DisordersNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A